nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—epilepsy syndrome	0.116	1	CbGaD
Boceprevir—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0386	0.0841	CbGbCtD
Boceprevir—ABCB1—Levetiracetam—epilepsy syndrome	0.0275	0.0599	CbGbCtD
Boceprevir—CYP3A5—Carbamazepine—epilepsy syndrome	0.0242	0.0528	CbGbCtD
Boceprevir—CYP3A5—Phenytoin—epilepsy syndrome	0.0217	0.0474	CbGbCtD
Boceprevir—CYP3A5—Phenobarbital—epilepsy syndrome	0.0194	0.0422	CbGbCtD
Boceprevir—CYP3A5—Midazolam—epilepsy syndrome	0.0191	0.0416	CbGbCtD
Boceprevir—ABCB1—Clobazam—epilepsy syndrome	0.019	0.0415	CbGbCtD
Boceprevir—CYP3A5—Diazepam—epilepsy syndrome	0.0184	0.04	CbGbCtD
Boceprevir—ABCB1—Lamotrigine—epilepsy syndrome	0.0183	0.0399	CbGbCtD
Boceprevir—ABCB1—Carbamazepine—epilepsy syndrome	0.0158	0.0344	CbGbCtD
Boceprevir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.015	0.0328	CbGbCtD
Boceprevir—CYP3A5—Valproic Acid—epilepsy syndrome	0.0145	0.0316	CbGbCtD
Boceprevir—ABCB1—Phenytoin—epilepsy syndrome	0.0141	0.0308	CbGbCtD
Boceprevir—CYP3A4—Felbamate—epilepsy syndrome	0.014	0.0305	CbGbCtD
Boceprevir—CYP3A4—Trimethadione—epilepsy syndrome	0.014	0.0305	CbGbCtD
Boceprevir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0132	0.0287	CbGbCtD
Boceprevir—ABCB1—Phenobarbital—epilepsy syndrome	0.0126	0.0275	CbGbCtD
Boceprevir—ABCB1—Midazolam—epilepsy syndrome	0.0124	0.0271	CbGbCtD
Boceprevir—ABCB1—Diazepam—epilepsy syndrome	0.012	0.0261	CbGbCtD
Boceprevir—CYP3A4—Clonazepam—epilepsy syndrome	0.0119	0.0259	CbGbCtD
Boceprevir—CYP3A4—Clobazam—epilepsy syndrome	0.0114	0.0249	CbGbCtD
Boceprevir—CYP3A4—Rufinamide—epilepsy syndrome	0.00969	0.0211	CbGbCtD
Boceprevir—CYP3A4—Carbamazepine—epilepsy syndrome	0.00945	0.0206	CbGbCtD
Boceprevir—CYP3A4—Primidone—epilepsy syndrome	0.00882	0.0192	CbGbCtD
Boceprevir—CYP3A4—Phenytoin—epilepsy syndrome	0.00847	0.0185	CbGbCtD
Boceprevir—CYP3A4—Propofol—epilepsy syndrome	0.0079	0.0172	CbGbCtD
Boceprevir—CTSK—skull—epilepsy syndrome	0.00779	0.13	CbGeAlD
Boceprevir—CYP3A4—Phenobarbital—epilepsy syndrome	0.00755	0.0165	CbGbCtD
Boceprevir—CYP3A4—Acetazolamide—epilepsy syndrome	0.00755	0.0165	CbGbCtD
Boceprevir—CTSK—forelimb—epilepsy syndrome	0.0075	0.126	CbGeAlD
Boceprevir—CYP3A4—Midazolam—epilepsy syndrome	0.00745	0.0162	CbGbCtD
Boceprevir—CYP3A4—Diazepam—epilepsy syndrome	0.00716	0.0156	CbGbCtD
Boceprevir—CYP3A4—Zonisamide—epilepsy syndrome	0.00699	0.0152	CbGbCtD
Boceprevir—CYP3A4—Valproic Acid—epilepsy syndrome	0.00564	0.0123	CbGbCtD
Boceprevir—CYP3A4—Topiramate—epilepsy syndrome	0.00509	0.0111	CbGbCtD
Boceprevir—CTSL—forebrain—epilepsy syndrome	0.00226	0.0378	CbGeAlD
Boceprevir—CTSL—telencephalon—epilepsy syndrome	0.00208	0.0347	CbGeAlD
Boceprevir—CTSV—medulla oblongata—epilepsy syndrome	0.002	0.0334	CbGeAlD
Boceprevir—CTSV—midbrain—epilepsy syndrome	0.00183	0.0305	CbGeAlD
Boceprevir—CTSV—spinal cord—epilepsy syndrome	0.00178	0.0298	CbGeAlD
Boceprevir—CTSL—medulla oblongata—epilepsy syndrome	0.00163	0.0273	CbGeAlD
Boceprevir—CTSV—head—epilepsy syndrome	0.00158	0.0265	CbGeAlD
Boceprevir—CTSV—nervous system—epilepsy syndrome	0.0015	0.0251	CbGeAlD
Boceprevir—CTSL—midbrain—epilepsy syndrome	0.00149	0.0249	CbGeAlD
Boceprevir—CTSS—forebrain—epilepsy syndrome	0.00149	0.0249	CbGeAlD
Boceprevir—CTSL—spinal cord—epilepsy syndrome	0.00145	0.0243	CbGeAlD
Boceprevir—CTSV—central nervous system—epilepsy syndrome	0.00144	0.0242	CbGeAlD
Boceprevir—CTSS—telencephalon—epilepsy syndrome	0.00137	0.0229	CbGeAlD
Boceprevir—CTSL—head—epilepsy syndrome	0.00129	0.0216	CbGeAlD
Boceprevir—CTSK—medulla oblongata—epilepsy syndrome	0.00123	0.0206	CbGeAlD
Boceprevir—CTSL—nervous system—epilepsy syndrome	0.00123	0.0205	CbGeAlD
Boceprevir—CTSL—central nervous system—epilepsy syndrome	0.00118	0.0197	CbGeAlD
Boceprevir—CTSL—cerebellum—epilepsy syndrome	0.00115	0.0193	CbGeAlD
Boceprevir—CTSV—brain—epilepsy syndrome	0.00115	0.0192	CbGeAlD
Boceprevir—CTSK—spinal cord—epilepsy syndrome	0.0011	0.0183	CbGeAlD
Boceprevir—CTSS—medulla oblongata—epilepsy syndrome	0.00108	0.018	CbGeAlD
Boceprevir—CTSS—midbrain—epilepsy syndrome	0.000984	0.0165	CbGeAlD
Boceprevir—CTSK—head—epilepsy syndrome	0.000974	0.0163	CbGeAlD
Boceprevir—CTSS—spinal cord—epilepsy syndrome	0.00096	0.0161	CbGeAlD
Boceprevir—Telaprevir—ALB—epilepsy syndrome	0.000948	0.512	CrCbGaD
Boceprevir—CTSL—brain—epilepsy syndrome	0.000937	0.0157	CbGeAlD
Boceprevir—CTSK—nervous system—epilepsy syndrome	0.000923	0.0154	CbGeAlD
Boceprevir—Telaprevir—ABCB1—epilepsy syndrome	0.000905	0.488	CrCbGaD
Boceprevir—CTSK—central nervous system—epilepsy syndrome	0.000889	0.0149	CbGeAlD
Boceprevir—CTSK—cerebellum—epilepsy syndrome	0.000869	0.0145	CbGeAlD
Boceprevir—CTSS—head—epilepsy syndrome	0.000854	0.0143	CbGeAlD
Boceprevir—CTSS—nervous system—epilepsy syndrome	0.000809	0.0135	CbGeAlD
Boceprevir—CTSS—central nervous system—epilepsy syndrome	0.000779	0.013	CbGeAlD
Boceprevir—CTSS—cerebellum—epilepsy syndrome	0.000761	0.0127	CbGeAlD
Boceprevir—CTSK—brain—epilepsy syndrome	0.000706	0.0118	CbGeAlD
Boceprevir—CTSS—brain—epilepsy syndrome	0.000619	0.0103	CbGeAlD
Boceprevir—ABCB1—forebrain—epilepsy syndrome	0.000263	0.0044	CbGeAlD
Boceprevir—ABCB1—telencephalon—epilepsy syndrome	0.000242	0.00405	CbGeAlD
Boceprevir—CYP3A4—nervous system—epilepsy syndrome	0.000202	0.00337	CbGeAlD
Boceprevir—CYP3A4—central nervous system—epilepsy syndrome	0.000194	0.00325	CbGeAlD
Boceprevir—ABCB1—medulla oblongata—epilepsy syndrome	0.00019	0.00318	CbGeAlD
Boceprevir—ABCB1—midbrain—epilepsy syndrome	0.000174	0.0029	CbGeAlD
Boceprevir—ABCB1—spinal cord—epilepsy syndrome	0.000169	0.00283	CbGeAlD
Boceprevir—ABCB1—head—epilepsy syndrome	0.000151	0.00252	CbGeAlD
Boceprevir—ABCB1—nervous system—epilepsy syndrome	0.000143	0.00239	CbGeAlD
Boceprevir—ABCB1—central nervous system—epilepsy syndrome	0.000137	0.0023	CbGeAlD
Boceprevir—ABCB1—cerebellum—epilepsy syndrome	0.000134	0.00225	CbGeAlD
Boceprevir—ABCB1—brain—epilepsy syndrome	0.000109	0.00183	CbGeAlD
Boceprevir—Headache—Vigabatrin—epilepsy syndrome	4.01e-05	0.000157	CcSEcCtD
Boceprevir—Hypertension—Pregabalin—epilepsy syndrome	4.01e-05	0.000157	CcSEcCtD
Boceprevir—Vomiting—Diazepam—epilepsy syndrome	4.01e-05	0.000157	CcSEcCtD
Boceprevir—Rash—Diazepam—epilepsy syndrome	3.97e-05	0.000155	CcSEcCtD
Boceprevir—Dermatitis—Diazepam—epilepsy syndrome	3.97e-05	0.000155	CcSEcCtD
Boceprevir—Visual impairment—Topiramate—epilepsy syndrome	3.96e-05	0.000155	CcSEcCtD
Boceprevir—Myalgia—Pregabalin—epilepsy syndrome	3.95e-05	0.000154	CcSEcCtD
Boceprevir—Arthralgia—Pregabalin—epilepsy syndrome	3.95e-05	0.000154	CcSEcCtD
Boceprevir—Chest pain—Pregabalin—epilepsy syndrome	3.95e-05	0.000154	CcSEcCtD
Boceprevir—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.95e-05	0.000154	CcSEcCtD
Boceprevir—Dizziness—Zonisamide—epilepsy syndrome	3.95e-05	0.000154	CcSEcCtD
Boceprevir—Headache—Diazepam—epilepsy syndrome	3.95e-05	0.000154	CcSEcCtD
Boceprevir—Anxiety—Pregabalin—epilepsy syndrome	3.94e-05	0.000154	CcSEcCtD
Boceprevir—Diarrhoea—Clonazepam—epilepsy syndrome	3.94e-05	0.000154	CcSEcCtD
Boceprevir—Anaemia—Gabapentin—epilepsy syndrome	3.93e-05	0.000154	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.92e-05	0.000153	CcSEcCtD
Boceprevir—Hypotension—Valproic Acid—epilepsy syndrome	3.92e-05	0.000153	CcSEcCtD
Boceprevir—Asthenia—Carbamazepine—epilepsy syndrome	3.91e-05	0.000153	CcSEcCtD
Boceprevir—Agitation—Gabapentin—epilepsy syndrome	3.91e-05	0.000153	CcSEcCtD
Boceprevir—Diarrhoea—Phenytoin—epilepsy syndrome	3.91e-05	0.000153	CcSEcCtD
Boceprevir—Discomfort—Pregabalin—epilepsy syndrome	3.9e-05	0.000153	CcSEcCtD
Boceprevir—Nausea—Fosphenytoin—epilepsy syndrome	3.9e-05	0.000152	CcSEcCtD
Boceprevir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.89e-05	0.000152	CcSEcCtD
Boceprevir—Erythema multiforme—Topiramate—epilepsy syndrome	3.89e-05	0.000152	CcSEcCtD
Boceprevir—Angioedema—Gabapentin—epilepsy syndrome	3.89e-05	0.000152	CcSEcCtD
Boceprevir—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.88e-05	0.000152	CcSEcCtD
Boceprevir—Vomiting—Felbamate—epilepsy syndrome	3.88e-05	0.000152	CcSEcCtD
Boceprevir—Dry mouth—Pregabalin—epilepsy syndrome	3.86e-05	0.000151	CcSEcCtD
Boceprevir—Pruritus—Carbamazepine—epilepsy syndrome	3.86e-05	0.000151	CcSEcCtD
Boceprevir—Rash—Felbamate—epilepsy syndrome	3.85e-05	0.00015	CcSEcCtD
Boceprevir—Eye disorder—Topiramate—epilepsy syndrome	3.84e-05	0.00015	CcSEcCtD
Boceprevir—Dermatitis—Felbamate—epilepsy syndrome	3.84e-05	0.00015	CcSEcCtD
Boceprevir—Malaise—Gabapentin—epilepsy syndrome	3.84e-05	0.00015	CcSEcCtD
Boceprevir—Tinnitus—Topiramate—epilepsy syndrome	3.84e-05	0.00015	CcSEcCtD
Boceprevir—Vertigo—Gabapentin—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Headache—Felbamate—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Confusional state—Pregabalin—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Cardiac disorder—Topiramate—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Flushing—Topiramate—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Syncope—Gabapentin—epilepsy syndrome	3.82e-05	0.000149	CcSEcCtD
Boceprevir—Leukopenia—Gabapentin—epilepsy syndrome	3.81e-05	0.000149	CcSEcCtD
Boceprevir—Dizziness—Clonazepam—epilepsy syndrome	3.81e-05	0.000149	CcSEcCtD
Boceprevir—Nausea—Vigabatrin—epilepsy syndrome	3.8e-05	0.000149	CcSEcCtD
Boceprevir—Vomiting—Zonisamide—epilepsy syndrome	3.8e-05	0.000148	CcSEcCtD
Boceprevir—Insomnia—Valproic Acid—epilepsy syndrome	3.79e-05	0.000148	CcSEcCtD
Boceprevir—Asthenia—Lamotrigine—epilepsy syndrome	3.78e-05	0.000148	CcSEcCtD
Boceprevir—Dizziness—Phenytoin—epilepsy syndrome	3.78e-05	0.000148	CcSEcCtD
Boceprevir—Rash—Zonisamide—epilepsy syndrome	3.76e-05	0.000147	CcSEcCtD
Boceprevir—Infection—Pregabalin—epilepsy syndrome	3.76e-05	0.000147	CcSEcCtD
Boceprevir—Paraesthesia—Valproic Acid—epilepsy syndrome	3.76e-05	0.000147	CcSEcCtD
Boceprevir—Palpitations—Gabapentin—epilepsy syndrome	3.76e-05	0.000147	CcSEcCtD
Boceprevir—Dermatitis—Zonisamide—epilepsy syndrome	3.76e-05	0.000147	CcSEcCtD
Boceprevir—Dizziness—Oxcarbazepine—epilepsy syndrome	3.76e-05	0.000147	CcSEcCtD
Boceprevir—Nausea—Diazepam—epilepsy syndrome	3.74e-05	0.000146	CcSEcCtD
Boceprevir—Loss of consciousness—Gabapentin—epilepsy syndrome	3.74e-05	0.000146	CcSEcCtD
Boceprevir—Headache—Zonisamide—epilepsy syndrome	3.74e-05	0.000146	CcSEcCtD
Boceprevir—Dyspnoea—Valproic Acid—epilepsy syndrome	3.74e-05	0.000146	CcSEcCtD
Boceprevir—Diarrhoea—Carbamazepine—epilepsy syndrome	3.73e-05	0.000146	CcSEcCtD
Boceprevir—Angiopathy—Topiramate—epilepsy syndrome	3.73e-05	0.000146	CcSEcCtD
Boceprevir—Pruritus—Lamotrigine—epilepsy syndrome	3.73e-05	0.000146	CcSEcCtD
Boceprevir—Shock—Pregabalin—epilepsy syndrome	3.73e-05	0.000146	CcSEcCtD
Boceprevir—Immune system disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000145	CcSEcCtD
Boceprevir—Nervous system disorder—Pregabalin—epilepsy syndrome	3.71e-05	0.000145	CcSEcCtD
Boceprevir—Cough—Gabapentin—epilepsy syndrome	3.71e-05	0.000145	CcSEcCtD
Boceprevir—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.71e-05	0.000145	CcSEcCtD
Boceprevir—Mediastinal disorder—Topiramate—epilepsy syndrome	3.71e-05	0.000145	CcSEcCtD
Boceprevir—Tachycardia—Pregabalin—epilepsy syndrome	3.7e-05	0.000144	CcSEcCtD
Boceprevir—Chills—Topiramate—epilepsy syndrome	3.69e-05	0.000144	CcSEcCtD
Boceprevir—Dyspepsia—Valproic Acid—epilepsy syndrome	3.69e-05	0.000144	CcSEcCtD
Boceprevir—Skin disorder—Pregabalin—epilepsy syndrome	3.68e-05	0.000144	CcSEcCtD
Boceprevir—Hypertension—Gabapentin—epilepsy syndrome	3.67e-05	0.000144	CcSEcCtD
Boceprevir—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.66e-05	0.000143	CcSEcCtD
Boceprevir—Vomiting—Clonazepam—epilepsy syndrome	3.66e-05	0.000143	CcSEcCtD
Boceprevir—Decreased appetite—Valproic Acid—epilepsy syndrome	3.64e-05	0.000142	CcSEcCtD
Boceprevir—Alopecia—Topiramate—epilepsy syndrome	3.63e-05	0.000142	CcSEcCtD
Boceprevir—Vomiting—Phenytoin—epilepsy syndrome	3.63e-05	0.000142	CcSEcCtD
Boceprevir—Rash—Clonazepam—epilepsy syndrome	3.63e-05	0.000142	CcSEcCtD
Boceprevir—Dermatitis—Clonazepam—epilepsy syndrome	3.62e-05	0.000142	CcSEcCtD
Boceprevir—Chest pain—Gabapentin—epilepsy syndrome	3.62e-05	0.000142	CcSEcCtD
Boceprevir—Myalgia—Gabapentin—epilepsy syndrome	3.62e-05	0.000142	CcSEcCtD
Boceprevir—Arthralgia—Gabapentin—epilepsy syndrome	3.62e-05	0.000142	CcSEcCtD
Boceprevir—Nausea—Felbamate—epilepsy syndrome	3.62e-05	0.000142	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.62e-05	0.000141	CcSEcCtD
Boceprevir—Vomiting—Oxcarbazepine—epilepsy syndrome	3.61e-05	0.000141	CcSEcCtD
Boceprevir—Fatigue—Valproic Acid—epilepsy syndrome	3.61e-05	0.000141	CcSEcCtD
Boceprevir—Anxiety—Gabapentin—epilepsy syndrome	3.61e-05	0.000141	CcSEcCtD
Boceprevir—Dizziness—Carbamazepine—epilepsy syndrome	3.61e-05	0.000141	CcSEcCtD
Boceprevir—Diarrhoea—Lamotrigine—epilepsy syndrome	3.61e-05	0.000141	CcSEcCtD
Boceprevir—Headache—Clonazepam—epilepsy syndrome	3.6e-05	0.000141	CcSEcCtD
Boceprevir—Rash—Phenytoin—epilepsy syndrome	3.6e-05	0.000141	CcSEcCtD
Boceprevir—Mental disorder—Topiramate—epilepsy syndrome	3.6e-05	0.000141	CcSEcCtD
Boceprevir—Dermatitis—Phenytoin—epilepsy syndrome	3.6e-05	0.000141	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.6e-05	0.000141	CcSEcCtD
Boceprevir—Rash—Oxcarbazepine—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Pain—Valproic Acid—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Constipation—Valproic Acid—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Headache—Phenytoin—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Erythema—Topiramate—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Malnutrition—Topiramate—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Discomfort—Gabapentin—epilepsy syndrome	3.58e-05	0.00014	CcSEcCtD
Boceprevir—Headache—Oxcarbazepine—epilepsy syndrome	3.56e-05	0.000139	CcSEcCtD
Boceprevir—Nausea—Zonisamide—epilepsy syndrome	3.55e-05	0.000139	CcSEcCtD
Boceprevir—Dry mouth—Gabapentin—epilepsy syndrome	3.54e-05	0.000138	CcSEcCtD
Boceprevir—Hypotension—Pregabalin—epilepsy syndrome	3.54e-05	0.000138	CcSEcCtD
Boceprevir—Flatulence—Topiramate—epilepsy syndrome	3.53e-05	0.000138	CcSEcCtD
Boceprevir—Dysgeusia—Topiramate—epilepsy syndrome	3.51e-05	0.000137	CcSEcCtD
Boceprevir—Confusional state—Gabapentin—epilepsy syndrome	3.5e-05	0.000137	CcSEcCtD
Boceprevir—Dizziness—Lamotrigine—epilepsy syndrome	3.49e-05	0.000136	CcSEcCtD
Boceprevir—Vomiting—Carbamazepine—epilepsy syndrome	3.47e-05	0.000136	CcSEcCtD
Boceprevir—Back pain—Topiramate—epilepsy syndrome	3.46e-05	0.000135	CcSEcCtD
Boceprevir—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.45e-05	0.000135	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.45e-05	0.000135	CcSEcCtD
Boceprevir—Infection—Gabapentin—epilepsy syndrome	3.45e-05	0.000135	CcSEcCtD
Boceprevir—Muscle spasms—Topiramate—epilepsy syndrome	3.44e-05	0.000135	CcSEcCtD
Boceprevir—Rash—Carbamazepine—epilepsy syndrome	3.44e-05	0.000134	CcSEcCtD
Boceprevir—Dermatitis—Carbamazepine—epilepsy syndrome	3.44e-05	0.000134	CcSEcCtD
Boceprevir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.43e-05	0.000134	CcSEcCtD
Boceprevir—Insomnia—Pregabalin—epilepsy syndrome	3.43e-05	0.000134	CcSEcCtD
Boceprevir—Nausea—Clonazepam—epilepsy syndrome	3.42e-05	0.000134	CcSEcCtD
Boceprevir—Headache—Carbamazepine—epilepsy syndrome	3.42e-05	0.000134	CcSEcCtD
Boceprevir—Shock—Gabapentin—epilepsy syndrome	3.42e-05	0.000134	CcSEcCtD
Boceprevir—Nervous system disorder—Gabapentin—epilepsy syndrome	3.41e-05	0.000133	CcSEcCtD
Boceprevir—Paraesthesia—Pregabalin—epilepsy syndrome	3.4e-05	0.000133	CcSEcCtD
Boceprevir—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.4e-05	0.000133	CcSEcCtD
Boceprevir—Nausea—Phenytoin—epilepsy syndrome	3.4e-05	0.000133	CcSEcCtD
Boceprevir—Tachycardia—Gabapentin—epilepsy syndrome	3.39e-05	0.000132	CcSEcCtD
Boceprevir—Dyspnoea—Pregabalin—epilepsy syndrome	3.38e-05	0.000132	CcSEcCtD
Boceprevir—Nausea—Oxcarbazepine—epilepsy syndrome	3.38e-05	0.000132	CcSEcCtD
Boceprevir—Vision blurred—Topiramate—epilepsy syndrome	3.37e-05	0.000132	CcSEcCtD
Boceprevir—Skin disorder—Gabapentin—epilepsy syndrome	3.37e-05	0.000132	CcSEcCtD
Boceprevir—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.36e-05	0.000131	CcSEcCtD
Boceprevir—Vomiting—Lamotrigine—epilepsy syndrome	3.35e-05	0.000131	CcSEcCtD
Boceprevir—Urticaria—Valproic Acid—epilepsy syndrome	3.33e-05	0.00013	CcSEcCtD
Boceprevir—Rash—Lamotrigine—epilepsy syndrome	3.32e-05	0.00013	CcSEcCtD
Boceprevir—Ill-defined disorder—Topiramate—epilepsy syndrome	3.32e-05	0.00013	CcSEcCtD
Boceprevir—Dermatitis—Lamotrigine—epilepsy syndrome	3.32e-05	0.00013	CcSEcCtD
Boceprevir—Abdominal pain—Valproic Acid—epilepsy syndrome	3.31e-05	0.000129	CcSEcCtD
Boceprevir—Body temperature increased—Valproic Acid—epilepsy syndrome	3.31e-05	0.000129	CcSEcCtD
Boceprevir—Anaemia—Topiramate—epilepsy syndrome	3.31e-05	0.000129	CcSEcCtD
Boceprevir—Headache—Lamotrigine—epilepsy syndrome	3.3e-05	0.000129	CcSEcCtD
Boceprevir—Decreased appetite—Pregabalin—epilepsy syndrome	3.29e-05	0.000129	CcSEcCtD
Boceprevir—Agitation—Topiramate—epilepsy syndrome	3.29e-05	0.000129	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.27e-05	0.000128	CcSEcCtD
Boceprevir—Fatigue—Pregabalin—epilepsy syndrome	3.27e-05	0.000128	CcSEcCtD
Boceprevir—Hypotension—Gabapentin—epilepsy syndrome	3.25e-05	0.000127	CcSEcCtD
Boceprevir—Nausea—Carbamazepine—epilepsy syndrome	3.24e-05	0.000127	CcSEcCtD
Boceprevir—Pain—Pregabalin—epilepsy syndrome	3.24e-05	0.000127	CcSEcCtD
Boceprevir—Constipation—Pregabalin—epilepsy syndrome	3.24e-05	0.000127	CcSEcCtD
Boceprevir—Malaise—Topiramate—epilepsy syndrome	3.23e-05	0.000126	CcSEcCtD
Boceprevir—Vertigo—Topiramate—epilepsy syndrome	3.22e-05	0.000126	CcSEcCtD
Boceprevir—Syncope—Topiramate—epilepsy syndrome	3.21e-05	0.000125	CcSEcCtD
Boceprevir—Leukopenia—Topiramate—epilepsy syndrome	3.21e-05	0.000125	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.16e-05	0.000124	CcSEcCtD
Boceprevir—Palpitations—Topiramate—epilepsy syndrome	3.16e-05	0.000124	CcSEcCtD
Boceprevir—Loss of consciousness—Topiramate—epilepsy syndrome	3.15e-05	0.000123	CcSEcCtD
Boceprevir—Insomnia—Gabapentin—epilepsy syndrome	3.14e-05	0.000123	CcSEcCtD
Boceprevir—Nausea—Lamotrigine—epilepsy syndrome	3.13e-05	0.000122	CcSEcCtD
Boceprevir—Cough—Topiramate—epilepsy syndrome	3.12e-05	0.000122	CcSEcCtD
Boceprevir—Feeling abnormal—Pregabalin—epilepsy syndrome	3.12e-05	0.000122	CcSEcCtD
Boceprevir—Paraesthesia—Gabapentin—epilepsy syndrome	3.12e-05	0.000122	CcSEcCtD
Boceprevir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.1e-05	0.000121	CcSEcCtD
Boceprevir—Dyspnoea—Gabapentin—epilepsy syndrome	3.1e-05	0.000121	CcSEcCtD
Boceprevir—Hypertension—Topiramate—epilepsy syndrome	3.09e-05	0.000121	CcSEcCtD
Boceprevir—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.09e-05	0.000121	CcSEcCtD
Boceprevir—Dyspepsia—Gabapentin—epilepsy syndrome	3.06e-05	0.000119	CcSEcCtD
Boceprevir—Chest pain—Topiramate—epilepsy syndrome	3.05e-05	0.000119	CcSEcCtD
Boceprevir—Myalgia—Topiramate—epilepsy syndrome	3.05e-05	0.000119	CcSEcCtD
Boceprevir—Arthralgia—Topiramate—epilepsy syndrome	3.05e-05	0.000119	CcSEcCtD
Boceprevir—Anxiety—Topiramate—epilepsy syndrome	3.04e-05	0.000119	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.03e-05	0.000118	CcSEcCtD
Boceprevir—Decreased appetite—Gabapentin—epilepsy syndrome	3.02e-05	0.000118	CcSEcCtD
Boceprevir—Discomfort—Topiramate—epilepsy syndrome	3.01e-05	0.000118	CcSEcCtD
Boceprevir—Urticaria—Pregabalin—epilepsy syndrome	3.01e-05	0.000118	CcSEcCtD
Boceprevir—Asthenia—Valproic Acid—epilepsy syndrome	3.01e-05	0.000117	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3e-05	0.000117	CcSEcCtD
Boceprevir—Fatigue—Gabapentin—epilepsy syndrome	2.99e-05	0.000117	CcSEcCtD
Boceprevir—Abdominal pain—Pregabalin—epilepsy syndrome	2.99e-05	0.000117	CcSEcCtD
Boceprevir—Body temperature increased—Pregabalin—epilepsy syndrome	2.99e-05	0.000117	CcSEcCtD
Boceprevir—Dry mouth—Topiramate—epilepsy syndrome	2.98e-05	0.000117	CcSEcCtD
Boceprevir—Constipation—Gabapentin—epilepsy syndrome	2.97e-05	0.000116	CcSEcCtD
Boceprevir—Pain—Gabapentin—epilepsy syndrome	2.97e-05	0.000116	CcSEcCtD
Boceprevir—Pruritus—Valproic Acid—epilepsy syndrome	2.96e-05	0.000116	CcSEcCtD
Boceprevir—Confusional state—Topiramate—epilepsy syndrome	2.95e-05	0.000115	CcSEcCtD
Boceprevir—Infection—Topiramate—epilepsy syndrome	2.9e-05	0.000113	CcSEcCtD
Boceprevir—Shock—Topiramate—epilepsy syndrome	2.88e-05	0.000112	CcSEcCtD
Boceprevir—Diarrhoea—Valproic Acid—epilepsy syndrome	2.87e-05	0.000112	CcSEcCtD
Boceprevir—Nervous system disorder—Topiramate—epilepsy syndrome	2.87e-05	0.000112	CcSEcCtD
Boceprevir—Feeling abnormal—Gabapentin—epilepsy syndrome	2.86e-05	0.000112	CcSEcCtD
Boceprevir—Thrombocytopenia—Topiramate—epilepsy syndrome	2.86e-05	0.000112	CcSEcCtD
Boceprevir—Tachycardia—Topiramate—epilepsy syndrome	2.85e-05	0.000111	CcSEcCtD
Boceprevir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.84e-05	0.000111	CcSEcCtD
Boceprevir—Skin disorder—Topiramate—epilepsy syndrome	2.84e-05	0.000111	CcSEcCtD
Boceprevir—Hyperhidrosis—Topiramate—epilepsy syndrome	2.83e-05	0.00011	CcSEcCtD
Boceprevir—Hypersensitivity—Pregabalin—epilepsy syndrome	2.79e-05	0.000109	CcSEcCtD
Boceprevir—Dizziness—Valproic Acid—epilepsy syndrome	2.77e-05	0.000108	CcSEcCtD
Boceprevir—Urticaria—Gabapentin—epilepsy syndrome	2.76e-05	0.000108	CcSEcCtD
Boceprevir—Body temperature increased—Gabapentin—epilepsy syndrome	2.75e-05	0.000107	CcSEcCtD
Boceprevir—Abdominal pain—Gabapentin—epilepsy syndrome	2.75e-05	0.000107	CcSEcCtD
Boceprevir—Hypotension—Topiramate—epilepsy syndrome	2.73e-05	0.000107	CcSEcCtD
Boceprevir—Asthenia—Pregabalin—epilepsy syndrome	2.72e-05	0.000106	CcSEcCtD
Boceprevir—Pruritus—Pregabalin—epilepsy syndrome	2.68e-05	0.000105	CcSEcCtD
Boceprevir—Vomiting—Valproic Acid—epilepsy syndrome	2.66e-05	0.000104	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.66e-05	0.000104	CcSEcCtD
Boceprevir—Insomnia—Topiramate—epilepsy syndrome	2.64e-05	0.000103	CcSEcCtD
Boceprevir—Rash—Valproic Acid—epilepsy syndrome	2.64e-05	0.000103	CcSEcCtD
Boceprevir—Dermatitis—Valproic Acid—epilepsy syndrome	2.64e-05	0.000103	CcSEcCtD
Boceprevir—Headache—Valproic Acid—epilepsy syndrome	2.62e-05	0.000103	CcSEcCtD
Boceprevir—Paraesthesia—Topiramate—epilepsy syndrome	2.62e-05	0.000103	CcSEcCtD
Boceprevir—Dyspnoea—Topiramate—epilepsy syndrome	2.61e-05	0.000102	CcSEcCtD
Boceprevir—Diarrhoea—Pregabalin—epilepsy syndrome	2.59e-05	0.000101	CcSEcCtD
Boceprevir—Dyspepsia—Topiramate—epilepsy syndrome	2.57e-05	0.000101	CcSEcCtD
Boceprevir—Hypersensitivity—Gabapentin—epilepsy syndrome	2.56e-05	0.0001	CcSEcCtD
Boceprevir—Decreased appetite—Topiramate—epilepsy syndrome	2.54e-05	9.93e-05	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.52e-05	9.86e-05	CcSEcCtD
Boceprevir—Fatigue—Topiramate—epilepsy syndrome	2.52e-05	9.85e-05	CcSEcCtD
Boceprevir—Dizziness—Pregabalin—epilepsy syndrome	2.5e-05	9.79e-05	CcSEcCtD
Boceprevir—Pain—Topiramate—epilepsy syndrome	2.5e-05	9.77e-05	CcSEcCtD
Boceprevir—Constipation—Topiramate—epilepsy syndrome	2.5e-05	9.77e-05	CcSEcCtD
Boceprevir—Asthenia—Gabapentin—epilepsy syndrome	2.49e-05	9.74e-05	CcSEcCtD
Boceprevir—Nausea—Valproic Acid—epilepsy syndrome	2.49e-05	9.73e-05	CcSEcCtD
Boceprevir—Pruritus—Gabapentin—epilepsy syndrome	2.46e-05	9.6e-05	CcSEcCtD
Boceprevir—Vomiting—Pregabalin—epilepsy syndrome	2.41e-05	9.41e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Topiramate—epilepsy syndrome	2.41e-05	9.41e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.39e-05	9.34e-05	CcSEcCtD
Boceprevir—Rash—Pregabalin—epilepsy syndrome	2.39e-05	9.33e-05	CcSEcCtD
Boceprevir—Dermatitis—Pregabalin—epilepsy syndrome	2.39e-05	9.33e-05	CcSEcCtD
Boceprevir—Diarrhoea—Gabapentin—epilepsy syndrome	2.38e-05	9.29e-05	CcSEcCtD
Boceprevir—Headache—Pregabalin—epilepsy syndrome	2.37e-05	9.27e-05	CcSEcCtD
Boceprevir—Urticaria—Topiramate—epilepsy syndrome	2.32e-05	9.07e-05	CcSEcCtD
Boceprevir—Abdominal pain—Topiramate—epilepsy syndrome	2.31e-05	9.03e-05	CcSEcCtD
Boceprevir—Body temperature increased—Topiramate—epilepsy syndrome	2.31e-05	9.03e-05	CcSEcCtD
Boceprevir—Dizziness—Gabapentin—epilepsy syndrome	2.3e-05	8.98e-05	CcSEcCtD
Boceprevir—Nausea—Pregabalin—epilepsy syndrome	2.25e-05	8.79e-05	CcSEcCtD
Boceprevir—Vomiting—Gabapentin—epilepsy syndrome	2.21e-05	8.63e-05	CcSEcCtD
Boceprevir—Rash—Gabapentin—epilepsy syndrome	2.19e-05	8.56e-05	CcSEcCtD
Boceprevir—Dermatitis—Gabapentin—epilepsy syndrome	2.19e-05	8.55e-05	CcSEcCtD
Boceprevir—Headache—Gabapentin—epilepsy syndrome	2.18e-05	8.5e-05	CcSEcCtD
Boceprevir—Hypersensitivity—Topiramate—epilepsy syndrome	2.15e-05	8.41e-05	CcSEcCtD
Boceprevir—Asthenia—Topiramate—epilepsy syndrome	2.1e-05	8.19e-05	CcSEcCtD
Boceprevir—Pruritus—Topiramate—epilepsy syndrome	2.07e-05	8.08e-05	CcSEcCtD
Boceprevir—Nausea—Gabapentin—epilepsy syndrome	2.06e-05	8.06e-05	CcSEcCtD
Boceprevir—Diarrhoea—Topiramate—epilepsy syndrome	2e-05	7.81e-05	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.99e-05	0.000185	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	1.99e-05	0.000185	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—epilepsy syndrome	1.98e-05	0.000185	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.98e-05	0.000185	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—epilepsy syndrome	1.97e-05	0.000184	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	1.97e-05	0.000183	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	1.96e-05	0.000182	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—epilepsy syndrome	1.95e-05	0.000182	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—epilepsy syndrome	1.95e-05	0.000182	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	1.95e-05	0.000182	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KDR—epilepsy syndrome	1.94e-05	0.000181	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FOS—epilepsy syndrome	1.94e-05	0.00018	CbGpPWpGaD
Boceprevir—Dizziness—Topiramate—epilepsy syndrome	1.93e-05	7.55e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—RELA—epilepsy syndrome	1.93e-05	0.00018	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—QDPR—epilepsy syndrome	1.92e-05	0.000178	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA4—epilepsy syndrome	1.92e-05	0.000178	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	1.91e-05	0.000178	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.91e-05	0.000178	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.91e-05	0.000178	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.91e-05	0.000178	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.91e-05	0.000178	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CASP8—epilepsy syndrome	1.89e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MTOR—epilepsy syndrome	1.89e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—epilepsy syndrome	1.87e-05	0.000175	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—epilepsy syndrome	1.87e-05	0.000175	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PRKCB—epilepsy syndrome	1.87e-05	0.000174	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6ST—epilepsy syndrome	1.86e-05	0.000174	CbGpPWpGaD
Boceprevir—Vomiting—Topiramate—epilepsy syndrome	1.86e-05	7.26e-05	CcSEcCtD
Boceprevir—Rash—Topiramate—epilepsy syndrome	1.84e-05	7.2e-05	CcSEcCtD
Boceprevir—Dermatitis—Topiramate—epilepsy syndrome	1.84e-05	7.19e-05	CcSEcCtD
Boceprevir—Headache—Topiramate—epilepsy syndrome	1.83e-05	7.15e-05	CcSEcCtD
Boceprevir—CTSV—Immune System—SRC—epilepsy syndrome	1.83e-05	0.00017	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SRC—epilepsy syndrome	1.83e-05	0.00017	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.81e-05	0.000169	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—COX3—epilepsy syndrome	1.8e-05	0.000168	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.79e-05	0.000167	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.77e-05	0.000165	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—epilepsy syndrome	1.74e-05	0.000162	CbGpPWpGaD
Boceprevir—Nausea—Topiramate—epilepsy syndrome	1.74e-05	6.78e-05	CcSEcCtD
Boceprevir—CTSS—Immune System—FGF2—epilepsy syndrome	1.71e-05	0.000159	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PFKL—epilepsy syndrome	1.71e-05	0.000159	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	1.71e-05	0.000159	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	1.71e-05	0.000159	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	1.71e-05	0.000159	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	1.71e-05	0.000159	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—POMC—epilepsy syndrome	1.7e-05	0.000159	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	1.7e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADK—epilepsy syndrome	1.7e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GLUD1—epilepsy syndrome	1.7e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PDXK—epilepsy syndrome	1.7e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FAR1—epilepsy syndrome	1.7e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CERS1—epilepsy syndrome	1.7e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.69e-05	0.000158	CbGpPWpGaD
Boceprevir—CTSK—Immune System—JUN—epilepsy syndrome	1.69e-05	0.000157	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.69e-05	0.000157	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.67e-05	0.000156	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.67e-05	0.000155	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—epilepsy syndrome	1.67e-05	0.000155	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—epilepsy syndrome	1.62e-05	0.000151	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.62e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—epilepsy syndrome	1.62e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RELA—epilepsy syndrome	1.59e-05	0.000148	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ATIC—epilepsy syndrome	1.56e-05	0.000146	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—UPB1—epilepsy syndrome	1.56e-05	0.000146	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NEU1—epilepsy syndrome	1.56e-05	0.000146	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MTOR—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—epilepsy syndrome	1.55e-05	0.000145	CbGpPWpGaD
Boceprevir—CTSK—Immune System—SRC—epilepsy syndrome	1.52e-05	0.000141	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.51e-05	0.00014	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.51e-05	0.00014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF2—epilepsy syndrome	1.51e-05	0.00014	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	1.5e-05	0.00014	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.49e-05	0.000138	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GBE1—epilepsy syndrome	1.45e-05	0.000135	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	1.45e-05	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.45e-05	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA4—epilepsy syndrome	1.45e-05	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.45e-05	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.45e-05	0.000135	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—epilepsy syndrome	1.44e-05	0.000134	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RELA—epilepsy syndrome	1.4e-05	0.00013	CbGpPWpGaD
Boceprevir—CTSS—Immune System—JUN—epilepsy syndrome	1.39e-05	0.00013	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.38e-05	0.000129	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MTOR—epilepsy syndrome	1.37e-05	0.000128	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	1.37e-05	0.000127	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COX3—epilepsy syndrome	1.36e-05	0.000127	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.34e-05	0.000125	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—epilepsy syndrome	1.33e-05	0.000124	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	1.33e-05	0.000124	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.3e-05	0.000121	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NT5E—epilepsy syndrome	1.29e-05	0.000121	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALAD—epilepsy syndrome	1.29e-05	0.000121	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.29e-05	0.00012	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.29e-05	0.00012	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.29e-05	0.00012	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.29e-05	0.00012	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.29e-05	0.00012	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—epilepsy syndrome	1.28e-05	0.000119	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—epilepsy syndrome	1.26e-05	0.000118	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SRC—epilepsy syndrome	1.25e-05	0.000116	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.24e-05	0.000116	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	1.24e-05	0.000115	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	1.24e-05	0.000115	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.23e-05	0.000114	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JUN—epilepsy syndrome	1.23e-05	0.000114	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	1.21e-05	0.000113	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.2e-05	0.000112	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—epilepsy syndrome	1.19e-05	0.000111	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADSL—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.18e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.17e-05	0.000109	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GLUL—epilepsy syndrome	1.16e-05	0.000108	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	1.14e-05	0.000106	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—epilepsy syndrome	1.14e-05	0.000106	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—epilepsy syndrome	1.14e-05	0.000106	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.13e-05	0.000106	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SRC—epilepsy syndrome	1.1e-05	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.1e-05	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.1e-05	0.000102	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—epilepsy syndrome	1.07e-05	9.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	1.07e-05	9.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.06e-05	9.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.05e-05	9.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.05e-05	9.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.05e-05	9.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.05e-05	9.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.05e-05	9.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.05e-05	9.76e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AQP1—epilepsy syndrome	1.04e-05	9.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.03e-05	9.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.02e-05	9.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1e-05	9.34e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	9.82e-06	9.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NT5E—epilepsy syndrome	9.77e-06	9.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALAD—epilepsy syndrome	9.77e-06	9.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	9.72e-06	9.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.59e-06	8.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.59e-06	8.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.59e-06	8.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.59e-06	8.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	9.54e-06	8.88e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—epilepsy syndrome	9.42e-06	8.77e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	9.36e-06	8.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	9.36e-06	8.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	9.32e-06	8.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	9.32e-06	8.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	9.12e-06	8.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADSL—epilepsy syndrome	8.94e-06	8.32e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.91e-06	8.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.91e-06	8.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.88e-06	8.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GLUL—epilepsy syndrome	8.76e-06	8.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	8.6e-06	8.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	8.55e-06	7.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.38e-06	7.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.33e-06	7.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	8.05e-06	7.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.99e-06	7.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.94e-06	7.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.94e-06	7.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.94e-06	7.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.94e-06	7.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.94e-06	7.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.92e-06	7.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AQP1—epilepsy syndrome	7.81e-06	7.27e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—epilepsy syndrome	7.76e-06	7.22e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	7.63e-06	7.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	7.44e-06	6.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	7.39e-06	6.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.26e-06	6.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.26e-06	6.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.26e-06	6.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.14e-06	6.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CHRM3—epilepsy syndrome	7.06e-06	6.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	7.06e-06	6.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.99e-06	6.51e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—epilepsy syndrome	6.83e-06	6.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.75e-06	6.29e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.75e-06	6.29e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	6.67e-06	6.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.35e-06	5.91e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	6.35e-06	5.91e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—epilepsy syndrome	6.32e-06	5.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.18e-06	5.75e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	6.03e-06	5.62e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.02e-06	5.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.02e-06	5.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	5.97e-06	5.56e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TH—epilepsy syndrome	5.94e-06	5.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.76e-06	5.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.74e-06	5.35e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.74e-06	5.35e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.62e-06	5.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	5.61e-06	5.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5.58e-06	5.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.51e-06	5.13e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.4e-06	5.03e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.32e-06	4.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.3e-06	4.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.03e-06	4.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	4.96e-06	4.62e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.96e-06	4.62e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—epilepsy syndrome	4.9e-06	4.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.81e-06	4.48e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.8e-06	4.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.79e-06	4.46e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.77e-06	4.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	4.76e-06	4.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.55e-06	4.24e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.5e-06	4.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TH—epilepsy syndrome	4.49e-06	4.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—epilepsy syndrome	4.43e-06	4.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.35e-06	4.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.35e-06	4.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—epilepsy syndrome	3.88e-06	3.62e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—epilepsy syndrome	3.8e-06	3.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.74e-06	3.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—epilepsy syndrome	3.69e-06	3.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.55e-06	3.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.46e-06	3.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.44e-06	3.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.34e-06	3.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—epilepsy syndrome	3.27e-06	3.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.1e-06	2.89e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.98e-06	2.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.95e-06	2.75e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.94e-06	2.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—epilepsy syndrome	2.93e-06	2.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—epilepsy syndrome	2.87e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.8e-06	2.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.77e-06	2.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TH—epilepsy syndrome	2.76e-06	2.57e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.61e-06	2.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—epilepsy syndrome	2.47e-06	2.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.31e-06	2.15e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.28e-06	2.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—epilepsy syndrome	2.25e-06	2.09e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.21e-06	2.06e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.06e-06	1.92e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	1.83e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.8e-06	1.68e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.77e-06	1.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.52e-06	1.41e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.39e-06	1.29e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.31e-06	1.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.21e-06	1.13e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—epilepsy syndrome	9.88e-07	9.2e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.09e-07	5.67e-06	CbGpPWpGaD
